ethylisopropylamiloride has been researched along with Cardiomyopathies in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gambassi, G | 1 |
Carbonin, P | 1 |
Capogrossi, MC | 1 |
1 other study available for ethylisopropylamiloride and Cardiomyopathies
Article | Year |
---|---|
[The arrhythmogenicity of alpha 1-adrenergic stimulation following myocardial acidosis].
Topics: Acidosis; Amiloride; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzopyrans; Cardiomyopa | 1992 |